Evidence map›Paper›PMID 28094574›Full record

ArticleLeukemia & lymphoma2017

Inferring a role for methylation of intergenic DNA in the regulation of genes aberrantly expressed in precursor B-cell acute lymphoblastic leukemia.

Md Almamun, Olha Kholod, Alexei J Stuckel, Benjamin T Levinson, Nathan T Johnson, Gerald L Arthur, J Wade Davis, Kristen H Taylor

Open access · greenAbstract read
In one paragraph

Article in Leukemia & lymphoma, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Md Almamuna Department of Pathology and Anatomical Sciences , University of Missouri-Columbia , Columbia , MO , USA.
Olha Kholoda Department of Pathology and Anatomical Sciences , University of Missouri-Columbia , Columbia , MO , USA.
Alexei J Stuckela Department of Pathology and Anatomical Sciences , University of Missouri-Columbia , Columbia , MO , USA.
Benjamin T Levinsona Department of Pathology and Anatomical Sciences , University of Missouri-Columbia , Columbia , MO , USA.
Nathan T Johnsonb Bioinformatics and Computational Biology , Worcester Polytechnic Institute , Worcester , MA , USA.
Gerald L Arthura Department of Pathology and Anatomical Sciences , University of Missouri-Columbia , Columbia , MO , USA.
J Wade Davisc Department of Health Management and Informatics , University of Missouri-Columbia , Columbia , MO , USA.
Kristen H Taylora Department of Pathology and Anatomical Sciences , University of Missouri-Columbia , Columbia , MO , USA.
University of Missouri · USWorcester Polytechnic Institute · US

Funding

Towards defining the functional methylome in acute lymphoblastic leukemiaR00CA132784 · NCI · UNIVERSITY OF MISSOURI-COLUMBIA · PI TAYLOR, KRISTEN H · 2011 to 2013
$694k
NCI NIH HHS R00 CA132784
6 · The paper itself

Abstract

A complete understanding of the mechanisms involved in the development of pre-B ALL is lacking. In this study, we integrated DNA methylation data and gene expression data to elucidate the impact of aberrant intergenic DNA methylation on gene expression in pre-B ALL. We found a subset of differentially methylated intergenic loci that were associated with altered gene expression in pre-B ALL patients. Notably, 84% of these regions were also bound by transcription factors (TF) known to play roles in differentiation and B-cell development in a lymphoblastoid cell line. Further, an overall downregulation of eRNA transcripts was observed in pre-B ALL patients and these transcripts were associated with the downregulation of putative target genes involved in B-cell migration, proliferation, and apoptosis. The identification of novel putative regulatory regions highlights the significance of intergenic DNA sequences and may contribute to the identification of new therapeutic targets for the treatment of pre-B ALL.

Indexed as

DNA, IntergenicDNA MethylationGene Expression Regulation, LeukemicCell Line, TumorEnhancer Elements, GeneticGene Expression ProfilingGenetic LociHumansPrecursor B-Cell Lymphoblastic Leukemia-LymphomaPromoter Regions, GeneticRNA, UntranslatedDNA, IntergenicRNA, Untranslatedacute lymphoblastic leukemiaDNA methylationenhancereRNAprecursor B-celltranscription factor

Identifiers

PMID28094574
PMCPMC5478429
OpenAlexW2576415127

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.